Bank of America’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-160
| Closed | – | – | 7743 |
|
|
2018
Q4 | $0 | Sell |
160
-60
| -27% | -$37 | ﹤0.01% | 7735 |
|
|
2018
Q3 | $0 | Buy |
220
+209
| +1,900% | +$350 | ﹤0.01% | 7712 |
|
|
2018
Q2 | $0 | Sell |
11
-1,091
| -99% | -$2.67K | ﹤0.01% | 7610 |
|
|
2018
Q1 | $3K | Buy |
1,102
+1,006
| +1,048% | +$2.54K | ﹤0.01% | 6873 |
|
|
2017
Q4 | $0 | Buy |
+96
| New | +$266 | ﹤0.01% | 7533 |
|
|
2017
Q3 | – | Sell |
-8,284
| Closed | -$33K | – | 7553 |
|
|
2017
Q2 | $33K | Sell |
8,284
-79
| -0.9% | -$344 | ﹤0.01% | 6051 |
|
|
2017
Q1 | $31K | Hold |
8,363
| – | – | ﹤0.01% | 6134 |
|
|
2016
Q4 | $16K | Sell |
8,363
-2,958
| -26% | -$10.7K | ﹤0.01% | 6433 |
|
|
2016
Q3 | $70K | Buy |
11,321
+552
| +5% | +$3.4K | ﹤0.01% | 5594 |
|
|
2016
Q2 | $48K | Buy |
10,769
+1,568
| +17% | +$10.2K | ﹤0.01% | 5851 |
|
|
2016
Q1 | $97K | Buy |
9,201
+5,993
| +187% | +$119K | ﹤0.01% | 5502 |
|
|
2015
Q4 | $95K | Buy |
3,208
+3,161
| +6,726% | +$95.6K | ﹤0.01% | 5750 |
|
|
2015
Q3 | $1K | Sell |
47
-237
| -83% | -$11.3K | ﹤0.01% | 7111 |
|
|
2015
Q2 | $17K | Buy |
284
+274
| +2,740% | +$19.3K | ﹤0.01% | 6408 |
|
|
2015
Q1 | $1K | Sell |
10
-783
| -99% | -$74.6K | ﹤0.01% | 6947 |
|
|
2014
Q4 | $74K | Buy |
793
+745
| +1,552% | +$71.1K | ﹤0.01% | 6103 |
|
|
2014
Q3 | $4K | Sell |
48
-700
| -94% | -$55.1K | ﹤0.01% | 7646 |
|
|
2014
Q2 | $67K | Buy |
748
+747
| +74,700% | +$45.8K | ﹤0.01% | 6444 |
|
|
2014
Q1 | $0 | Sell |
1
-15
| -94% | -$495 | ﹤0.01% | 8375 |
|
|
2013
Q4 | $0 | Sell |
16
-34
| -68% | -$810 | ﹤0.01% | 8368 |
|
|
2013
Q3 | $1K | Sell |
50
-967
| -95% | -$31.1K | ﹤0.01% | 7790 |
|
|
2013
Q2 | $37K | Buy |
+1,017
| New | +$38.1K | ﹤0.01% | 6733 |
|
Bank of America's PTX Position: Q1 2019 in Review
Bank of America sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 160 shares.
Bank of America first reported a position in PTX in Q2 2013 and held it in 22 quarters. The position peaked at $97K in Q1 2016. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.
- Bank of America reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
- Bank of America sold 160 Pernix Therapeutics Holdings, Inc. shares in Q1 2019.
- Bank of America first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 22 quarters.
- Bank of America's Pernix Therapeutics Holdings, Inc. position peaked at $97K in Q1 2016.
- 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.
Based on Bank of America's 13F filing for Q1 2019, filed 15 May 2019.